"to be honest, that was what i had almost expected," she said..
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
orchid pharma faces liquidation as lenders reject resolution plan
.
.
johns hopkins all children's hospital. [jim damaske |times]